- Home
- ALIT vs MLTX Comparison
ALIT vs MLTX Comparison
Compare ALIT & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALIT
- MLTX
- Stock Information
- Founded
- ALIT 2017
- MLTX 2021
- Country
- ALIT United States
- MLTX Switzerland
- Employees
- ALIT N/A
- MLTX N/A
- Industry
- ALIT Business Services
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- ALIT Consumer Discretionary
- MLTX Health Care
- Exchange
- ALIT Nasdaq
- MLTX Nasdaq
- Market Cap
- ALIT 3.0B
- MLTX 2.8B
- IPO Year
- ALIT N/A
- MLTX N/A
- Fundamental
- Price
- ALIT $3.80
- MLTX $52.40
- Analyst Decision
- ALIT Strong Buy
- MLTX Strong Buy
- Analyst Count
- ALIT 8
- MLTX 7
- Target Price
- ALIT $8.94
- MLTX $74.83
- AVG Volume (30 Days)
- ALIT 8.2M
- MLTX 506.4K
- Earning Date
- ALIT 08-05-2025
- MLTX 08-05-2025
- Dividend Yield
- ALIT 4.20%
- MLTX N/A
- EPS Growth
- ALIT N/A
- MLTX N/A
- EPS
- ALIT N/A
- MLTX N/A
- Revenue
- ALIT $2,311,000,000.00
- MLTX N/A
- Revenue This Year
- ALIT $2.53
- MLTX N/A
- Revenue Next Year
- ALIT $4.02
- MLTX N/A
- P/E Ratio
- ALIT N/A
- MLTX N/A
- Revenue Growth
- ALIT N/A
- MLTX N/A
- 52 Week Low
- ALIT $3.80
- MLTX $31.42
- 52 Week High
- ALIT $8.93
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- ALIT 19.49
- MLTX 54.60
- Support Level
- ALIT $4.09
- MLTX $51.08
- Resistance Level
- ALIT $4.45
- MLTX $53.78
- Average True Range (ATR)
- ALIT 0.24
- MLTX 2.27
- MACD
- ALIT -0.20
- MLTX -0.42
- Stochastic Oscillator
- ALIT 0.00
- MLTX 55.43
About ALIT Alight Inc.
Alight Inc is a technology-enabled services company delivering human capital management solutions to many of complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth and leaves benefits) solutions, currently operates under one reportable segment, Employer Solutions. The Company completed the Divestiture of Alight's Professional Services segment and Alight's Payroll & HCM Outsourcing business within the Employer Solutions segment. The company operates in USA states and International market too.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.